Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Monoclonal Gammopathy of Undetermined Significance (MGUS) Clinical Trials

2 recruiting trials for Monoclonal Gammopathy of Undetermined Significance (MGUS). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06140524

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple...

This study is researching an investigational drug called linvoseltamab ("study drug") in participants at moderate risk of developing multiple myeloma (about 3 to 10% average...

Sponsor: Regeneron PharmaceuticalsEnrolling: 11613 locations
RECRUITINGNCT06690593

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

This is an observational case-control study, aiming to systematically analyze the gut microbiome characteristics of patients with monoclonal gammopathy of undetermined...

Sponsor: Zhujiang HospitalEnrolling: 29901 location